VivoSim Labs, Inc. Selling, General and Administrative Expense
VivoSim Labs, Inc. (VIVS) reported Selling, General and Administrative Expense of $1.65 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-12
- VivoSim Labs, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.65M, a 15.68% decline year-over-year.
- VivoSim Labs, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.10M, a 10.40% decline year-over-year.
- VivoSim Labs, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.64M, a 4.33% decline year-over-year.
- VivoSim Labs, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.74M, a 5.26% increase year-over-year.
- VivoSim Labs, Inc. selling, general and administrative expense for fiscal 2026 was $7.43M, a 3.89% decline from fiscal 2025.
- VivoSim Labs, Inc. selling, general and administrative expense for fiscal 2025 was $7.73M, a 20.28% decline from fiscal 2024.
- VivoSim Labs, Inc. selling, general and administrative expense for fiscal 2024 was $9.70M, a 5.22% increase from fiscal 2023.
- VivoSim Labs, Inc. selling, general and administrative expense for fiscal 2023 was $9.22M, a 4.59% decline from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 59 month | Selling, General and Administrative Expense 62 month | Selling, General and Administrative Expense 65 month | Selling, General and Administrative Expense 68 month | Selling, General and Administrative Expense 71 month | Selling, General and Administrative Expense 74 month | Selling, General and Administrative Expense 77 month | Selling, General and Administrative Expense 80 month | Selling, General and Administrative Expense 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.65M 10-Q · filed 2026-08-12 | $3.75M derived: sum of 2 quarters · filed 2026-08-12 | $5.38M derived: sum of 3 quarters · filed 2026-08-12 | $7.12M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2026-03-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $3.74M derived: sum of 2 quarters · filed 2026-07-14 | $5.48M derived: sum of 3 quarters · filed 2026-07-14 | $7.43M 10-K · filed 2026-07-14 | ||||||||||||
| 2025-12-31 | $1.64M 10-Q · filed 2026-02-11 | $3.38M derived: sum of 2 quarters · filed 2026-02-11 | $5.33M 10-Q · filed 2026-02-11 | $7.67M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2025-09-30 | $1.74M 10-Q · filed 2025-11-06 | $3.69M 10-Q · filed 2025-11-06 | $6.04M derived: sum of 3 quarters · filed 2026-08-12 | $7.75M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2025-06-30 | $1.95M 10-Q · filed 2026-08-12 | $4.30M derived: sum of 2 quarters · filed 2026-08-12 | $6.01M derived: sum of 3 quarters · filed 2026-08-12 | $7.66M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2025-03-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $4.06M derived: sum of 2 quarters · filed 2026-07-14 | $5.71M derived: sum of 3 quarters · filed 2026-07-14 | $7.73M 10-K · filed 2026-07-14 | ||||||||||||
| 2024-12-31 | $1.71M 10-Q · filed 2026-02-11 | $3.36M derived: sum of 2 quarters · filed 2026-02-11 | $5.38M 10-Q · filed 2026-02-11 | $7.45M derived: sum of 4 quarters · filed 2026-02-11 | ||||||||||||
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-06 | $3.67M 10-Q · filed 2025-11-06 | $5.74M derived: sum of 3 quarters · filed 2025-11-06 | $7.99M derived: sum of 4 quarters · filed 2025-11-06 | ||||||||||||
| 2024-06-30 | $2.02M 10-Q · filed 2025-08-12 | $4.08M derived: sum of 2 quarters · filed 2025-08-12 | $6.33M derived: sum of 3 quarters · filed 2025-08-12 | $9.11M derived: sum of 4 quarters · filed 2025-08-12 | ||||||||||||
| 2024-03-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05 | $4.31M derived: sum of 2 quarters · filed 2025-06-05 | $7.09M derived: sum of 3 quarters · filed 2025-06-05 | $9.70M 10-K · filed 2025-06-05 | ||||||||||||
| 2023-12-31 | $2.25M 10-Q · filed 2025-02-19 | $5.03M derived: sum of 2 quarters · filed 2025-02-19 | $7.63M 10-Q · filed 2025-02-19 | $10.13M derived: sum of 4 quarters · filed 2025-02-19 | ||||||||||||
| 2023-09-30 | $2.78M 10-Q · filed 2024-11-08 | $5.38M 10-Q · filed 2024-11-08 | $7.88M derived: sum of 3 quarters · filed 2024-11-08 | $10.18M derived: sum of 4 quarters · filed 2024-11-08 | ||||||||||||
| 2023-06-30 | $2.60M 10-Q · filed 2024-08-05 | $5.10M derived: sum of 2 quarters · filed 2024-08-05 | $7.40M derived: sum of 3 quarters · filed 2024-08-05 | $9.60M derived: sum of 4 quarters · filed 2024-08-05 | ||||||||||||
| 2023-03-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $4.80M derived: sum of 2 quarters · filed 2024-05-31 | $7.00M derived: sum of 3 quarters · filed 2024-05-31 | $9.22M 10-K · filed 2024-05-31 | ||||||||||||
| 2022-12-31 | $2.31M 10-Q · filed 2024-02-08 | $4.50M derived: sum of 2 quarters · filed 2024-02-08 | $6.72M 10-Q · filed 2024-02-08 | $9.00M derived: sum of 4 quarters · filed 2024-02-08 | ||||||||||||
| 2022-09-30 | $2.20M 10-Q · filed 2023-11-09 | $4.42M 10-Q · filed 2023-11-09 | $6.70M derived: sum of 3 quarters · filed 2023-11-09 | $9.27M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||
| 2022-06-30 | $2.22M 10-Q · filed 2023-08-10 | $4.50M derived: sum of 2 quarters · filed 2023-08-10 | $7.07M derived: sum of 3 quarters · filed 2023-08-10 | $9.90M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||||
| 2022-03-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $4.85M derived: sum of 2 quarters · filed 2023-07-14 | $7.68M derived: sum of 3 quarters · filed 2023-07-14 | $9.66M 10-K · filed 2023-07-14 | ||||||||||||
| 2021-12-31 | $2.57M 10-Q · filed 2023-02-09 | $5.40M derived: sum of 2 quarters · filed 2023-02-09 | $7.38M 10-Q · filed 2023-02-09 | $9.31M derived: sum of 4 quarters · filed 2023-02-09 | ||||||||||||
| 2021-09-30 | $2.83M 10-Q · filed 2022-11-10 | $4.81M 10-Q · filed 2022-11-10 | $6.73M derived: sum of 3 quarters · filed 2022-11-10 | $8.82M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||
| 2021-06-30 | $1.98M 10-Q · filed 2022-08-11 | $3.90M derived: sum of 2 quarters · filed 2022-08-11 | $5.99M derived: sum of 3 quarters · filed 2022-08-11 | $14.92M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||
| 2021-03-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | $4.01M derived: sum of 2 quarters · filed 2022-06-10 | $12.94M derived: sum of 3 quarters · filed 2022-06-10 | $15.72M 10-K · filed 2022-06-10 | ||||||||||||
| 2020-12-31 | $2.09M 10-Q · filed 2022-02-14 | $11.01M derived: sum of 2 quarters · filed 2022-02-14 | $13.80M 10-Q · filed 2022-02-14 | $16.82M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||
| 2020-09-30 | $8.92M 10-Q · filed 2021-11-08 | $11.71M 10-Q · filed 2021-11-08 | $14.73M derived: sum of 3 quarters · filed 2021-11-08 | $20.10M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||
| 2020-06-30 | $2.79M 10-Q · filed 2021-08-06 | $5.81M derived: sum of 2 quarters · filed 2021-08-06 | $11.18M derived: sum of 3 quarters · filed 2021-08-06 | $17.53M derived: sum of 4 quarters · filed 2021-08-06 | ||||||||||||
| 2020-03-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $8.40M derived: sum of 2 quarters · filed 2021-06-15 | $14.74M derived: sum of 3 quarters · filed 2021-06-15 | $18.06M 10-K · filed 2021-06-15 | ||||||||||||
| 2019-12-31 | $5.37M 10-Q · filed 2021-02-08 | $11.72M derived: sum of 2 quarters · filed 2021-02-08 | $15.04M 10-Q · filed 2021-02-08 | $18.37M derived: sum of 4 quarters · filed 2021-02-08 | ||||||||||||
| 2019-09-30 | $6.35M 10-Q · filed 2020-11-05 | $9.66M 10-Q · filed 2020-11-05 | $13.00M derived: sum of 3 quarters · filed 2020-11-05 | $16.39M derived: sum of 4 quarters · filed 2020-11-05 | ||||||||||||
| 2019-06-30 | $3.31M 10-Q · filed 2020-08-10 | $6.65M derived: sum of 2 quarters · filed 2020-08-10 | $10.04M derived: sum of 3 quarters · filed 2020-08-10 | $13.68M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $6.72M derived: sum of 2 quarters · filed 2020-05-28 | $10.36M derived: sum of 3 quarters · filed 2020-05-28 | $15.13M 10-K · filed 2020-05-28 | ||||||||||||
| 2018-12-31 | $3.39M 10-Q · filed 2020-02-10 | $7.03M derived: sum of 2 quarters · filed 2020-02-10 | $11.79M 10-Q · filed 2020-02-10 | $16.23M derived: sum of 4 quarters · filed 2020-02-10 | ||||||||||||
| 2018-09-30 | $3.64M 10-Q · filed 2019-11-07 | $8.41M 10-Q · filed 2019-11-07 | $12.84M derived: sum of 3 quarters · filed 2019-11-07 | $17.70M derived: sum of 4 quarters · filed 2019-11-07 | ||||||||||||
| 2018-06-30 | $4.77M 10-Q · filed 2019-08-08 | $9.20M derived: sum of 2 quarters · filed 2019-08-08 | $14.06M derived: sum of 3 quarters · filed 2019-08-08 | $19.80M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||||
| 2018-03-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $9.30M derived: sum of 2 quarters · filed 2019-06-03 | $15.03M derived: sum of 3 quarters · filed 2019-06-03 | $20.89M 10-K · filed 2019-06-03 | ||||||||||||
| 2017-12-31 | $4.87M 10-Q · filed 2019-02-07 | $10.60M derived: sum of 2 quarters · filed 2019-02-07 | $16.46M 10-Q · filed 2019-02-07 | $22.24M derived: sum of 4 quarters · filed 2019-02-07 | ||||||||||||
| 2017-09-30 | $5.74M 10-Q · filed 2018-11-08 | $11.59M 10-Q · filed 2018-11-08 | $17.38M derived: sum of 3 quarters · filed 2018-11-08 | $22.92M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||||
| 2017-06-30 | $5.86M 10-Q · filed 2018-08-09 | $11.64M derived: sum of 2 quarters · filed 2018-08-09 | $17.19M derived: sum of 3 quarters · filed 2018-08-09 | $23.10M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||
| 2017-03-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $11.33M derived: sum of 2 quarters · filed 2018-05-31 | $17.25M derived: sum of 3 quarters · filed 2018-05-31 | $22.30M 10-K · filed 2018-05-31 | ||||||||||||
| 2016-12-31 | $5.55M 10-Q · filed 2018-02-08 | $11.46M derived: sum of 2 quarters · filed 2018-02-08 | $16.52M 10-Q · filed 2018-02-08 | $20.96M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||||
| 2016-09-30 | $5.92M 10-Q · filed 2017-11-09 | $10.97M 10-Q · filed 2017-11-09 | $15.41M derived: sum of 3 quarters · filed 2018-05-31 | $21.62M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||||
| 2016-06-30 | $5.06M 10-Q · filed 2017-08-09 | $9.49M derived: sum of 2 quarters · filed 2018-05-31 | $15.71M derived: sum of 3 quarters · filed 2018-05-31 | $22.55M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||||
| 2016-03-31 | $4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $10.65M derived: sum of 2 quarters · filed 2018-05-31 | $17.50M derived: sum of 3 quarters · filed 2018-05-31 | $22.12M 10-K · filed 2018-05-31 | ||||||||||||
| 2015-12-31 | $6.21M 10-Q · filed 2017-02-09 | $13.06M derived: sum of 2 quarters · filed 2017-02-09 | $17.68M 10-Q · filed 2017-02-09 | $22.28M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||||
| 2015-09-30 | $6.85M 10-Q · filed 2016-11-03 | $11.47M 10-Q · filed 2016-11-03 | $16.07M derived: sum of 3 quarters · filed 2017-06-07 | $19.94M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||||
| 2015-06-30 | $4.62M 10-Q · filed 2016-08-04 | $9.22M derived: sum of 2 quarters · filed 2017-06-07 | $13.10M derived: sum of 3 quarters · filed 2017-06-07 | $18.87M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||||
| 2015-03-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $8.47M derived: sum of 2 quarters · filed 2017-06-07 | $14.25M derived: sum of 3 quarters · filed 2017-06-07 | $17.95M 10-K · filed 2017-06-07 | ||||||||||||
| 2014-12-31 | $3.88M 10-Q · filed 2016-02-08 | $9.65M derived: sum of 2 quarters · filed 2016-02-08 | $13.35M 10-Q · filed 2016-02-08 | $17.66M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||||
| 2014-09-30 | $5.78M 10-Q · filed 2015-11-09 | $9.47M 10-Q · filed 2015-11-09 | $13.79M derived: sum of 3 quarters · filed 2016-06-09 | $16.16M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||||
| 2014-06-30 | $3.69M 10-Q · filed 2015-08-10 | $8.01M derived: sum of 2 quarters · filed 2016-06-09 | $10.39M derived: sum of 3 quarters · filed 2016-06-09 | $14.39M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||||
| 2014-03-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | $6.69M derived: sum of 2 quarters · filed 2016-06-09 | $10.70M derived: sum of 3 quarters · filed 2016-06-09 | $13.05M 10-K · filed 2016-06-09 | $25.59M 10-K · filed 2014-06-10 | |||||||||||
| 2013-12-31 | $2.38M 10-Q · filed 2015-02-06 | $2.40M 10-Q · filed 2014-02-06 | $6.38M derived: sum of 2 quarters · filed 2015-02-06 | $8.74M 10-Q · filed 2015-02-06 | $8.81M 10-Q · filed 2014-02-06 | $11.53M derived: sum of 4 quarters · filed 2015-06-09 | $21.35M 10-Q · filed 2014-02-06 | |||||||||
| 2013-09-30 | $4.00M 10-Q · filed 2014-11-07 | $4.03M 10-Q · filed 2013-11-08 | $6.36M 10-Q · filed 2014-11-07 | $6.40M 10-Q · filed 2013-11-08 | $9.15M derived: sum of 3 quarters · filed 2015-06-09 | $11.29M derived: sum of 4 quarters · filed 2015-06-09 | $18.94M 10-Q · filed 2013-11-08 | |||||||||
| 2013-06-30 | $2.36M 10-Q · filed 2014-08-08 | $2.38M 10-Q · filed 2013-08-09 | $5.15M derived: sum of 2 quarters · filed 2015-06-09 | $7.29M derived: sum of 3 quarters · filed 2015-06-09 | $10.27M derived: sum of 4 quarters · filed 2015-06-09 | $14.92M 10-Q · filed 2013-08-09 | ||||||||||
| 2013-03-31 | $2.79M 10-K · filed 2015-06-09 | $4.93M derived: sum of 2 quarters · filed 2015-06-09 | $7.91M derived: sum of 3 quarters · filed 2015-06-09 | $8.97M derived: sum of 4 quarters · filed 2015-06-09 | $12.54M 10-KT · filed 2013-05-24 | |||||||||||
| 2012-12-31 | $2.14M 10-Q · filed 2014-02-06 | $5.12M derived: sum of 2 quarters · filed 2014-02-06 | $6.18M 10-Q · filed 2014-02-06 | $7.08M 10-K · filed 2015-06-09 | $9.75M 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | $2.98M 10-Q · filed 2013-11-08 | $2.98M 10-Q · filed 2012-11-14 | $4.04M 10-Q · filed 2013-11-08 | $4.94M 10-Q · filed 2012-11-14 | $5.54M derived: sum of 4 quarters · filed 2015-06-09 | $7.61M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $1.06M 10-Q · filed 2013-08-09 | $1.06M 10-Q · filed 2012-08-14 | $1.96M 10-Q · filed 2012-08-14 | $2.56M derived: sum of 3 quarters · filed 2015-06-09 | $3.11M derived: sum of 4 quarters · filed 2015-06-09 | $4.62M 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | $902.00K 10-K · filed 2015-06-09 | $901.84K 10-Q · filed 2012-05-15 | $1.51M derived: sum of 2 quarters · filed 2015-06-09 | $2.06M derived: sum of 3 quarters · filed 2015-06-09 | $2.39M derived: sum of 4 quarters · filed 2015-06-09 | $3.57M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $603.40K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $1.15M derived: sum of 2 quarters · filed 2014-06-10 | $1.49M derived: sum of 3 quarters · filed 2014-06-10 | $1.73M 10-K · filed 2014-06-10 | ||||||||||||
| 2011-09-30 | $550.16K 10-Q · filed 2012-11-14 | $886.10K derived: sum of 2 quarters · filed 2012-11-14 | $1.13M 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $335.95K 10-Q · filed 2012-08-14 | $579.44K 10-Q · filed 2012-08-14 | ||||||||||||||
| 2011-03-31 | $243.49K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $578.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |